Biotechnology Stocks II Performance Guide: Viridian Therapeutics, Inc. (VRDN)
VRDN has no dividends.
Table and Chart of VRDN Performance
See what a $1,000 investment in VRDN is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| VRDN Returns | |
|---|---|
| Start Date | Jul-31-2014 |
| Start Price | $1,332.00 |
| End Date | May-17-2024 |
| End Price | $13.45 |
| # Prices | 119 |
| Min Date | Mar-31-2020 |
| Min Price | $6.69 |
| Max Date | Jul-31-2014 |
| Max Price | $1,332.00 |
| Total Return | -98.99% |
| Annualized Return | -37.09% |
| Current Value of $1,000 Purchase | $10 |
| Number Returns | 7,021 |
| Average Return | -46.72% |
| Number Profitable Returns | 1,320 |
| Percent Profitable Returns | 18.80% |
| Number Unprofitable Returns | 5,701 |
| Percent Unprofitable Returns | 81.20% |
| Profitable to Unprofitable Returns Ratio | 0.23 |
| VRDN Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $858,413,000 |
| Beta | 1.166 | Price to Sales | 3,176.36 |
| Earnings per Share | $-4.4900 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 4.24 |
| PRICE DATA | |
| 52 Week High | $28.35 |
| 52 Week Low | $10.93 |
| Analyst Target Price | $36.5 |
| 50-Day Moving Average | $15.82 |
| 200-Day Moving Average | $17.2 |
| FINANCIAL DATA | |
| Revenue per Share | $0.006 |
| Revenue | $288,000 |
| Profit Margin | 0% |
| Return on Equity | -46.8% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
VRDN Compare Returns with S&P 500
VRDN Trendline Chart
VRDN Moving Average Chart
VRDN Stock Return Map - See Patterns of Gains and Losses
VRDN Stock Returns/Purchase Dates